For children with diagnosed hepatitis B newly, the drug was administered based on the age and weight from the young child
For children with diagnosed hepatitis B newly, the drug was administered based on the age and weight from the young child. entecavir for anti-hepatitis B treatment. The kids were grouped into two groupings: one band of kids stopped acquiring lamivudine twelve months after procedure (n=7) independently, while the various other group didn’t (n=15). Results From…